HEALTH CARE UTILIZATION (HCU) BY BREAST CANCER (BC) AND NON-HODGKIN LYMPHOMA (NHL) PATIENTS WITH CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA (FN) IN THE NETHERLANDS

被引：0
|
作者：
Issa, D. E. [1 ]
van Herk-Sukel, M. P. P. [2 ]
Gelderblom, H. [3 ]
Houweling, L. M. A. [2 ]
Jager, A. [4 ]
De La Orden, M. [5 ]
Lugtenburg, P. J. [4 ]
van der Werf-Langenberg, M. E. [6 ]
Nortier, J. W. R. [3 ]
de Jong, F. A. [6 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] PHARMO Inst, Utrecht, Netherlands
[3] Leiden Univ Med Ctr, Leiden, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
[5] Amgen Inc, Uxbridge, Middx, England
[6] Amgen BV, Breda, Netherlands
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A435 / A435
页数：1
相关论文
共 50 条
  • [41] Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria
    Salako, Omolola
    Okunade, Kehinde Sharafadeen
    Adeniji, Adeoluwa Akeem
    Fagbenro, Gabriel Timilehin
    Afolaranmi, Oluwasegun Joshua
    ECANCERMEDICALSCIENCE, 2021, 15
  • [42] A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of chop chemotherapy in patients with aggressive non-Hodgkin's lymphoma.
    Intragumtornchai, T
    Sutheesophon, J
    Sutcharitjan, P
    Swasdikul, D
    BLOOD, 1998, 92 (10) : 225B - 225B
  • [43] History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis
    Chao, Chun
    Rodriguez, Roberto
    Page, John H.
    Yang, Su-Jau
    Huynh, Julie
    Chia, Victoria M.
    LEUKEMIA & LYMPHOMA, 2015, 56 (01) : 72 - 79
  • [44] Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin's lymphoma patients under Taiwan's national health insurance system
    Wen, Tsun-Jen
    Wen, Yu-Wen
    Chien, Chun-Ru
    Chiang, Shao-Chin
    Hsu, William Wei-Yuan
    Shen, Li-Jiuan
    Hsiao, Fei-Yuan
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2017, 23 (02) : 288 - 293
  • [45] Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2)
    Yokoyama, Masahiro
    Kusano, Yoshiharu
    Nishihara, Anna
    Inoue, Norihito
    Nishimura, Noriko
    Mishima, Yuko
    Terui, Yasuhito
    Nukada, Tomoyuki
    Nomura, Takanobu
    Hatake, Kiyohiko
    SUPPORTIVE CARE IN CANCER, 2020, 28 (02) : 571 - 579
  • [46] Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2)
    Masahiro Yokoyama
    Yoshiharu Kusano
    Anna Nishihara
    Norihito Inoue
    Noriko Nishimura
    Yuko Mishima
    Yasuhito Terui
    Tomoyuki Nukada
    Takanobu Nomura
    Kiyohiko Hatake
    Supportive Care in Cancer, 2020, 28 : 571 - 579
  • [47] Efficacy of standard CHOP chemotherapy in elderly patients with poor risk non-Hodgkin's lymphoma (NHL)
    Doorduijn, JK
    Van der Holt, B
    Breed, WPM
    Van der Hem, KG
    Van Imhoff, GW
    Kramer, MHH
    Kooy, MV
    Van Oers, MHJ
    Ossenkoppele, GJ
    Richel, DJ
    Roozendaal, KJ
    Van't Veer, MB
    Verdonck, LF
    Verhoef, G
    Wijermans, PW
    Sonneveld, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 149 - 149
  • [48] Blood Levels of Organochlorines Before, During and After Chemotherapy Among Non-Hodgkin Lymphoma (NHL) Patients
    Baris, Dalsu
    Vermeulen, Roel
    Purdue, Mark
    Wilson, Wyndham
    Pellizzari, Edo
    Hartge, Patricia
    Rothman, Nathaniel
    EPIDEMIOLOGY, 2009, 20 (06) : S235 - S235
  • [49] Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
    Fust, Kelly
    Li, Xiaoyan
    Maschio, Michael
    Villa, Guillermo
    Parthan, Anju
    Barron, Richard
    Weinstein, Milton C.
    Somers, Luc
    Hoefkens, Caroline
    Lyman, Gary H.
    PHARMACOECONOMICS, 2017, 35 (04) : 425 - 438
  • [50] Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
    Kelly Fust
    Xiaoyan Li
    Michael Maschio
    Guillermo Villa
    Anju Parthan
    Richard Barron
    Milton C. Weinstein
    Luc Somers
    Caroline Hoefkens
    Gary H. Lyman
    PharmacoEconomics, 2017, 35 : 425 - 438
12345